XML 64 R6.htm IDEA: XBRL DOCUMENT v3.20.1
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
shares in Thousands, $ in Thousands
Series A Preferred Stock
Qualitytech, LP
Common stock
Limited Partner
Series A Preferred Stock
Qualitytech, LP
Series A Preferred Stock
Accumulated dividends in excess of earnings
Series A Preferred Stock
Total stockholders' Equity
Series A Preferred Stock
Series B Preferred Stock
Qualitytech, LP
Common stock
Limited Partner
Series B Preferred Stock
Qualitytech, LP
Series B Preferred Stock
Accumulated dividends in excess of earnings
Series B Preferred Stock
Total stockholders' Equity
Series B Preferred Stock
Qualitytech, LP
Preferred stock
Limited Partner
Qualitytech, LP
Common stock
Limited Partner
Qualitytech, LP
Common stock
General Partner
Qualitytech, LP
Accumulated other comprehensive income (loss)
Qualitytech, LP
Preferred stock
Common stock
Additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated dividends in excess of earnings
Total stockholders' Equity
Noncontrolling interests
Total
Beginning balance at Dec. 31, 2018                     $ 407,477 $ 886,866 $ 1 $ 2,344 $ 1,296,687 $ 407,477 $ 511 $ 1,062,473 $ 2,073 $ (278,548) $ 1,193,986 $ 102,701 $ 1,296,687
Beginning balance, shares at Dec. 31, 2018                     7,443 57,799       7,443 51,123            
Net cumulative effect upon Topic ASC 842 adoption                       $ (1,813)     (1,813)         (1,813) (1,813)   (1,813)
Net share activity through equity award plan                       $ 741     741   $ 3 660     663 78 741
Net share activity through equity award plan, shares                       229         231            
Increase (Decrease) in fair value of derivative contracts                           (9,853) (9,853)       (8,775)   (8,775) (1,078) (9,853)
Equity-based compensation expense                       $ 3,300     3,300     2,928     2,928 372 3,300
Adjustment to expenses net                     $ (42)       (42) $ (42)         (42)   (42)
Proceeds net of fees from common equity offering                       $ 158,663     158,663   $ 40 148,650     148,690 9,973 158,663
Proceeds net of fees from common equity offering (in shares)                       4,000         4,000            
Dividends declared on Preferred Stock $ (1,906) $ (1,906) $ (1,906) $ (1,906) $ (1,906) $ (5,139) $ (5,139) $ (5,139) $ (5,139) $ (5,139)         (7,045)               (7,045)
Dividends declared to common stockholders                       $ (24,371)     (24,371)         (24,371) (24,371)   (24,371)
Dividends declared to noncontrolling interests                                           (2,935) (2,935)
Partnership distributions                       (2,935)     (2,935)                
Net income                       21,148     21,148         19,558 19,558 1,590 21,148
Ending balance at Mar. 31, 2019                     $ 407,435 $ 1,034,554 1 (7,509) 1,434,480 $ 407,435 $ 554 1,214,711 (6,702) (292,219) 1,323,779 110,701 1,434,480
Ending balance, shares at Mar. 31, 2019                     7,443 62,028       7,443 55,354            
Beginning balance at Dec. 31, 2019                     $ 407,435 $ 1,064,481 1 (27,465) 1,444,451 $ 407,435 $ 582 1,330,444 (24,642) (376,002) 1,337,817 106,634 1,444,451
Beginning balance, shares at Dec. 31, 2019                     7,443 64,901       7,443 58,228            
Partners' Capital, Beginning Balance at Dec. 31, 2019                             1,444,451                
Net share activity through equity award plan                       $ (1,458)     (1,458)   $ 3 (1,312)     (1,309) (149) (1,458)
Net share activity through equity award plan, shares                       238         240            
Increase (Decrease) in fair value of derivative contracts                           (36,715) (36,715)       (33,155)   (33,155) (3,560) (36,715)
Foreign currency translation adjustments                           (223) (223)       (201)   (201) (22) (223)
Equity-based compensation expense                       $ 4,875     4,875     4,377     4,377 498 4,875
Proceeds net of fees from settlement of forward shares                       $ 83,217     83,217   $ 19 78,516     78,535 4,682 83,217
Proceeds net of fees from settlement of forward shares (in shares)                       1,930         1,930            
Dividends declared on Preferred Stock $ (1,906) $ (1,906) $ (1,906) $ (1,906) $ (1,906) $ (5,139) $ (5,139) $ (5,139) $ (5,139) $ (5,139)         (7,045)               (7,045)
Dividends declared to common stockholders                       $ (28,393)     (28,393)         (28,393) (28,393)   (28,393)
Dividends declared to noncontrolling interests                                           (3,133) (3,133)
Partnership distributions                       (3,133)     (3,133)                
Net income                       8,120     8,120         8,010 8,010 110 8,120
Ending balance at Mar. 31, 2020                     $ 407,435 $ 1,120,664 $ 1 $ (64,403) 1,463,696 $ 407,435 $ 604 $ 1,412,025 $ (57,998) $ (403,430) $ 1,358,636 $ 105,060 $ 1,463,696
Ending balance, shares at Mar. 31, 2020                     7,443 67,069       7,443 60,398            
Partners' Capital, Ending Balance at Mar. 31, 2020                             $ 1,463,696